Esmolol: a viable option for current antinociceptive clinical research

We acknowledge the Letter to the Editor authored by Dr Nair.[1][1] We agree with Dr Nair on several points, and respectfully disagree on others. Our Daring Discourse[2][2] was first submitted in 2017, and therefore the review/opinion article by Sultana et al [3][3] was not available to us at the